glp-1 mood changes Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] GLP-1 and Depression Risk: Mental
Description
and Region/Country Geography: Industry: Last Updated: Feb 2025 The GLP-1 Analogues Market was valued at approximately USD 37 Billion in 2023 and is expected to grow at a substantial CAGR of around 28% during the forecast period (2024-2032) owing to the rising prevalence of type 2 diabetes and obesity
![glp-1 mood changes Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] GLP-1 and Depression Risk: Mental](https://plexusdx.com/cdn/shop/articles/b6_6c4059f3-c1e5-4d62-b6f0-057ecf3aa7da.jpg?v=1780515304&width=4608)
Individual results vary and are not guaranteed
![glp-1 mood changes Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] GLP-1 and Depression Risk: Mental](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs43440-021-00274-8/MediaObjects/43440_2021_274_Figa_HTML.png)
70 to No
J., Linge, J., Birkenfeld, A
![glp-1 mood changes Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] GLP-1 and Depression Risk: Mental](https://www.readymind.com.au/wp-content/uploads/GLP-1-psychology-mood-.png)
GLP-1 medications are prescribed to treat type 2 diabetes and help with weight management
Always consult a qualified healthcare professional before making decisions about medications
![glp-1 mood changes Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] GLP-1 and Depression Risk: Mental](https://cdn2.psychologytoday.com/assets/styles/article_inline_full_caption/public/field_blog_entry_images/2026-04/glp1_vs_naltrexone_for_aud_dr_gold_0.png.jpg?itok=x0nfyhU6)